| Polomar Health Services, Inc. (TRFE) | |||||||||||||||||||||||||||||||||||||||||||||||||
| Q4-CY2025 | Q3-CY2025 | Q2-CY2025 | Q1-CY2025 | Q4-CY2024 | Q3-CY2024 | Q2-CY2024 | Q1-CY2024 | Q4-CY2023 | Q3-CY2023 | Q2-CY2023 | Q1-CY2023 | Q4-CY2022 | Q3-CY2022 | Q2-CY2022 | Q1-CY2022 | Q4-CY2021 | Q3-CY2021 | Q2-CY2021 | Q1-CY2021 | Q4-CY2020 | Q3-CY2020 | Q2-CY2020 | Q1-CY2020 | Q4-CY2019 | Q3-CY2019 | Q2-CY2019 | Q1-CY2019 | Q4-CY2018 | Q3-CY2018 | Q2-CY2018 | Q1-CY2018 | Q4-CY2017 | Q3-CY2017 | Q2-CY2017 | Q1-CY2017 | Q4-CY2016 | Q3-CY2016 | Q2-CY2016 | Q1-CY2016 | Q4-CY2015 | Q3-CY2015 | Q2-CY2015 | Q1-CY2015 | Q4-CY2014 | Q3-CY2014 | Q2-CY2014 | Q1-CY2014 | Q4-CY2013 | |
| Balance Sheet Date | 2025-Sep-30 | 2025-Jun-30 | 2025-Mar-31 | 2024-Dec-31 | 2024-Sep-30 | 2024-Jun-30 | 2024-Mar-31 | 2023-Dec-31 | |||||||||||||||||||||||||||||||||||||||||
| Fiscal Period | Q3-FY2025 | Q2-FY2025 | Q1-FY2025 | Q4-FY2024 | Q3-FY2024 | Q2-FY2024 | Q1-FY2024 | Q4-FY2023 | |||||||||||||||||||||||||||||||||||||||||
| Operating Cash Flow | (352,659$) | (187,780$) | (45,577$) | (314,995$) | (624,671$) | (247,908$) | (164,763$) | (220,116$) | (149,742$) | (91,423$) | (73,026$) | ||||||||||||||||||||||||||||||||||||||
| Investing Cash Flow | 0$ | (38,774$) | (41,458$) | ||||||||||||||||||||||||||||||||||||||||||||||
| Purchases of Property and Equipment | 0$ | 38,774$ | 41,458$ | ||||||||||||||||||||||||||||||||||||||||||||||
| Financing Cash Flow | 386,835$ | 63,127$ | 168,717$ | 304,984$ | 722,908$ | 278,546$ | 225,406$ | 60,378$ | 290,269$ | (78,893$) | 45,742$ | ||||||||||||||||||||||||||||||||||||||
| End Cash Position | 38,854$ | 4,678$ | 129,331$ | 6,191$ | 294$ | 244$ | 224$ | ||||||||||||||||||||||||||||||||||||||||||
| Exchange Rate Effect | |||||||||||||||||||||||||||||||||||||||||||||||||
| Dividends Paid | |||||||||||||||||||||||||||||||||||||||||||||||||
| Unlevered Free Cash Flow | (352,659$) | (187,780$) | (45,577$) | (314,995$) | (624,671$) | (286,682$) | (206,221$) | (220,116$) | (149,742$) | (91,423$) | (73,026$) | ||||||||||||||||||||||||||||||||||||||